Third, Butein possesses unique advantages by simultaneously inhibiting TWEAK-FN14 (immune modulation), STAT3 (proliferation), and Nrf2 (oxidative stress), aligning with the multifactorial pathogenesis of cSCC. The gene discussed is TNFRSF12A; the disease is skin squamous cell carcinoma.